BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Neuroimmunology is entering a defining moment. With the $470M 
 buyout of Vigil’s TREM2 asset\, Ventus’ NLRP3 inhibitor in phase 2a\, and
  promising phase 3 BTKi readouts from Sanofi and Roche\, the field is beg
 inning to show encouraging signs of clinical viability in targeting neuro
 inflammation. Now the real race begins. Uncovering the next wave of mecha
 nisms\, biomarkers\, and translational strategies that will move beyond t
 oday’s successes and unlock new therapeutic frontiers in neurodegeneratio
 n and neuroimmune-driven psychiatric disease.\n\nThe 8th Neuroimmunology 
 Drug Development Summit is the industry’s only meeting fully dedicated to
  advancing novel neuroinflammatory targets\, uniquely bridging cutting-ed
 ge academic discovery with the practical lens of drug development. This y
 ear’s expanded program goes deeper than ever into emerging glial biology 
 (TREM2 and beyond)\, peripheral immune pathways\, and the technologies re
 defining how we discover\, validate\, and measure neuroinflammatory targe
 ts.\n\nAcross three days\, 50+ discovery\, preclinical\, and translationa
 l leaders from Biogen\, Sanofi\, Merck\, Lundbeck\, Vigil Neuroscience\, 
 Bristol Myers Squibb and more will unite to share hyper-current insights 
 on merging neuroinflammatory mechanisms\, cutting-edge glial models and o
 mics technologies accelerating target discovery\, next-generation biomark
 ers enhancing translation\, and early clinical signals from novel neuroim
 mune-targeting therapies.\n\nJoin the global neuroimmunology community th
 is year and help define the future of immune-modulating therapies for the
  brain.\n\nURLs:Website: https://go.evvnt.com/3395845-0?pid=185Tickets: h
 ttps://go.evvnt.com/3395845-2?pid=185Brochure: https://go.evvnt.com/33958
 45-3?pid=185\n\nDate and Time: On Tue\, 14 Apr 2026 09:00 - Thu\, 16 Apr 
 2026 17:00\n\nVenue Details: Wyndham Boston Beacon Hill\, 5 Blossom Stree
 t\, Boston\, Massachusetts\, 02114\, United States\n\nCategory: Conferenc
 es | Science\, Health and Medicine | Pharmaceuticals\n\nPrices:Industry P
 ricing - Conference + Workshop Day: USD 4297.00\,Industry Pricing - Confe
 rence Only: USD 3099.00\,Academic Pricing - Conference + Workshop Day: US
 D 3697.00\,Academic Pricing - Conference Only: USD 2699.00\,Vendor Pricin
 g - Conference + Workshop Day: USD 5197.00\,Vendor Pricing - Conference O
 nly: USD 3799.00\n\nSpeakers: Agnes Cheong\, Senior Scientist\, Sanofi\, 
 Andrew Kaplan\, Principal Scientist and Lab Head\, Bristol Myers Squibb\,
  Borislav Dejanovic\, Senior Director\, Translational Sciences and Extern
 al Innovation\, Vigil Neuroscience\, a Sanofi Company\, Dimitry Ofengeim\
 , Head of Precision Neurology and Neuroinflammation\, Sanofi\, Ioannis-Al
 exandros Gampierakis\, Postdoctoral Research Fellow\, Inflammation and Im
 munology\, Pfizer\, Kevin Dines\, Scientific Executive Director\, Bristol
  Myers Squibb \, Markus Kummer\, Senior Principal Research Scientist\, Ab
 bVie\, Rebecca Mathew\, Senior Principal Scientist\, Merck\, Tarek Samad\
 , Senior Vice President and Global Head\, Research\, Lundbeck\, Christian
  Mirescu. Chief Scientific Officer\, Monument Biosciences\, Hella Kohlhof
 \, Chief Scientific Officer\, Immunic Therapeutics\, Jagadeesh Rao\, Prin
 cipal Scientist\, IGC PHARMA\, Julia Kuhn\, Associate Director - Target D
 iscovery and Genomics\, Alector \, Niels Plath\, Chief Scientific Officer
 \, Muna Therapeutics\, Paul Song\, Chief Executive Officer\, NKGen Biotec
 h\, Peter Flynn\, President and Chief Executive Officer\, Arialys Therape
 utics\, Ralph Minter\, Chief Scientific Officer\, Alchemab Therapeutics\n
DTEND:20260416T170000
DTSTAMP:20260512T214304Z
DTSTART:20260414T090000
LOCATION:Wyndham Boston Beacon Hill\, 5\, Blossom Street\, Boston\, Massac
 husetts\, 02114\,
SEQUENCE:0
SUMMARY:Neuroimmunology is entering a defining moment. With the $470M buyo
 ut of Vigil’s TREM2 asset\, Ventus’ NLRP3 inhibitor in phase 2a\, and pro
 mising pha...
UID:2a67ce31-573e-446b-b7f2-ea982d151ea7
END:VEVENT
END:VCALENDAR